About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, October 10th, 2013

The QualityStocks
Daily Stock List


Global Ecology Corp. (GLEC)

Wallstreetlivechat reported earlier on Global Ecology Corp. (GLEC), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Founded in 1986, Montclair, New Jersey-based Global Ecology Corp.’s goal is to purchase or jointly develop, proprietary and licensed technologies, which focus on point-of-use water purification systems, mineral ionization formulas, and organic soil amendment remediation solutions. The Company, via their subsidiary and joint ventures, engages in the production and sale of soil and water remediation technologies. The specific targeting of the Company’s expanding portfolio of licensed proprietary environmental remediation technologies are at contaminated water and soil environments.

Global Ecology’s technologies include ionized mineral solutions technology for agriculture, horticulture, aquiculture, and food processing. Moreover, their technologies include mobile water purification systems, water remediation, and wastewater and wastewater-effluent-recycling. They provide site owners, engineers, consultants, governmental agencies, and the academic community unbiased design and cost-effective remediation strategies.

The Company’s field-proven biotechnology-based solutions are used worldwide to effectively manage complex, challenging environmental liabilities. Their remediation solutions are proven to treat the widest range of organic and inorganic contaminants through accelerating natural attenuation in water and soil.
In addition, Global Ecology, in concert with two soil microbiologists and a well-known agronomist, has completed development of several organic soil amendments and additives using the Company’s proprietary formula for environmentally safe and natural remediation of waste materials (Organic Soil Amendments Division OSA1000™). The Company believes the OSA1000™ Product Groups will improve and increase productivity in almost all agricultural applications.

Pertaining to mobile water purification systems, the Company provides flexible and mobile water purification systems for use in regions where safe and clean drinking water is scarce or affected by natural disasters. Concerning water remediation, Global Ecology can treat reservoirs and other large bodies of water, while keeping water infrastructure delivery systems free of harmful bacteria and bio-fouling organisms.

Furthermore, using their wastewater-recycling process, the Company provides what they believe is the world’s greenest and most environmentally correct wastewater system.

Global Ecology Corp. (GLEC), closed Thursday's trading session at $0.009, up 12.50%, on 722,450 volume with 12 trades. The average volume for the last 60 days is 479,323 and the stock's 52-week low/high is $0.0011/$0.0085.

North Bay Resources, Inc. (NBRI)

FeedBlitz and Stock Guru reported previously on North Bay Resources, Inc. (NBRI), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Headquartered in Skippack, Pennsylvania, North Bay Resources, Inc. is a junior mining enterprise. The Company’s mission is to build a portfolio of viable mining prospects around the world and develop them via subsidiaries and Joint Venture (JV) partners to their full economic potential. North Bay Resources looks to acquire, develop, and exploit natural resource properties with extensive reserves of precious metals, including gold, silver, platinum, and palladium, and base metals, including copper, zinc, lead, molybdenum, and others. The foundation of their business plan is the Generative Business Model.

The design of the Generative Business Model is to leverage their properties into near-term revenue streams even during the earliest stages of exploration and development. The Company accomplishes this through entering into sales, JV, and/or option contracts with other mining companies, for which North Bay Resources generates revenue by way of payments in cash, stock, and other consideration.  

The Company has more than 150 mineral and placer claims encompassing approximately 60,000 acres throughout British Columbia. In the United States, North Bay Resources owns the Ruby Gold Mine in Sierra County, California. The Company is currently looking to acquire additional operating mines in the western United States. North Bay Resources expects to generate long-term revenue from their acquisition of the Ruby Mine, through the acquisition of additional mines, and by the development of their properties, either independently or through JV partners, into operating mines.

The Ruby Mine, a/k/a the Ruby Gold Project, is a fully permitted underground placer and lode mine located near Downieville in Sierra County. The Ruby Property covers approximately 1,755 acres. The property consists of the subsurface mineral rights of two patented claims totaling approximately 435 acres and 30 unpatented claims containing approximately 1,320 acres. The equipment, fixed assets, and infrastructure in place include a 1,000 yard per day placer wash plant, a 50-ton per day quartz mill, 6,000 feet of tracked haulage, and related support equipment necessary for underground mining operations.

Today, North Bay Resources reported that they achieved another major milestone. This is with the recovery of the Company’s first ounces of specimen gold at the Ruby Mine. This marks the first production of gold at the Ruby Mine since the 1990's. Additionally, it marks the first gold produced since North Bay acquired the Ruby Mine in 2011. The gold was recovered during a preliminary geological survey of a newly-accessible area of the Ruby Mine positioned toward the south end of the Black Channel workings.

North Bay Resources, Inc. (NBRI), closed Thursday's trading session at $0.05, up 21.95%, on 1,307,502 volume with 97 trades. The average volume for the last 60 days is 346,736 and the stock's 52-week low/high is $0.029/$0.13.

Nutra Pharma Corp. (NPHC)

Pumps and Dumps, PennyStocks24, Wallstreetlivechat, and Winston Small Cap reported recently on Nutra Pharma Corp. (NPHC), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets’ OTCQB, Nutra Pharma Corp. operates as a biotechnology company. They market several drug products for sale for the treatment of pain under the brands Cobroxin® and Nyloxin™. The Company, through their subsidiaries, carries out basic drug discovery research and clinical development. Nutra Pharma also looks for strategic licensing partnerships to reduce the risks associated with the drug development process. The Nutra Pharma holding that acts as the drug discovery arm for the Company is ReceptoPharm.

The Company specializes in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. These include Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain.

Nutra Pharma’s ReceptoPharm is developing proprietary therapeutic protein products chiefly for the prevention and treatment of viral and neurological diseases in humans. The wholly-owned medical devices subsidiary of Nutra Pharma is Designer Diagnostics. The Company engages in the marketing and sales of rapid diagnostics test kits for infectious diseases, including Tuberculosis and NonTuberculous Mycobacteria (NTM).

Nutra Pharma’s Nyloxin™ is an over-the-counter (OTC) pain reliever for the treatment of moderate to severe chronic pain. It is available as an oral spray and as a topical gel. Cobroxin® is the first over-the-counter pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. The drug will be available as an oral spray and as a topical gel.

Yesterday, Nutra Pharma provided updates on the sales and marketing activities of TCN, a distributor of Nutra Pharma's Over-the-Counter (OTC) pain reliever, Nyloxin®. In September 2012, Nutra Pharma announced the start of distribution efforts by the TCN group of direct distributors. Since then, TCN has worked diligently to introduce Nyloxin® to approximately 40,000 distributors in the U.S. and close to 400,000 distributors worldwide.

Mr. Dalton Johnson, Chief Executive Officer of TCN, said, "The Nyloxin products continue to represent a wonderful opportunity for our distributors. These are pain-relievers and anti-inflammatory drugs that have provided great results with almost no risk of side effects. We are now in the process of merging our databases that will eventually double our distributor outreach with the goal to achieve significant sales through our distributors that will provide continuity as they use and order the product every month."

Nutra Pharma Corp. (NPHC), closed Thursday's trading session at $0.0178, even for the day, on 3,299,419 volume with 67 trades. The average volume for the last 60 days is 5,709,732 and the stock's 52-week low/high is $0.0035/$0.0445.

First Liberty Power Corp. (FLPC)

PennyStocks24 and Stock Analyzer reported earlier on First Liberty Power Corp. (FLPC), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Based in Las Vegas, Nevada, First Liberty Power Corp. is a diversified mine exploration and development enterprise concentrating on bringing to market "Mined in America" strategic industrial minerals. The Company’s main target elements include lithium, antimony, vanadium, uranium, and graphite. First Liberty Power is continuing to amass a portfolio of properties and interests in several important areas. These range in stage of development from advanced stage exploration through to production ready.  

The Company holds interests in the Lida Valley and Smokey Valley properties in Nevada for the exploration and production of Lithium. These properties are close to the only United States-based producing Lithium operation, Chemetall Foote. The Lida Valley project covers 58 placer claims comprising 9,280 acres. The Smokey Valley project consists of approximately 70 placer claims covering 11,200 acres.

First Liberty also acquired a 40.5 percent net interest in an Antimony (Stibnite) project in Reno, Nevada (the Fencemaker Antimony project). In addition, the Company has interests in the San Juan Vanadium/Uranium project in Utah. The San Juan Property consists of 13 lode claims, totaling 260 acres, positioned within the Colorado Plateau near the Utah-Colorado border.

Earlier this year, First Liberty Power announced that they signed a Letter of Intent (LOI) with Group8 Mining Innovations to acquire $1.5 million for the purchase of equipment to process ore from the Fencemaker Operation. The above-industry standard of First Liberty’s milling equipment will permit an upgrade of all permitted antimony (stibnite) ore from Fencemaker to an industry standard 60 percent concentrate using an advanced, clean milling process. The Company will also have the opportunity to use any excess milling capacity to potentially process ore from other compatible local mining operations.

In late September, First Liberty Power announced that they recently brought their management team together in Lovelock, Nevada to review final Fencemaker mining preparations. According to Company CEO, Mr. Don Nicholson, the meeting included Board members and strategic partners. The timetable for Fencemaker mining is depending on the installation of culvert drainage pipes and water management tanks, already underway, and a final operational site inspection. Furthermore, last week, the Company announced that they are drawing close to the production and sales of stibnite ore (antimony) from their Fencemaker mine.

First Liberty Power Corp. (FLPC), closed Thursday's trading session at $0.017, down 10.05%, on 2,049,992 volume with 81 trades. The average volume for the last 60 days is 4,459,187 and the stock's 52-week low/high is $0.0021/$0.034.

Bio-Matrix Scientific Group, Inc. (BMSN)

PennyStocks24, Pumps and Dumps, StockBomb.com, StockLockandLoad, StockRockandRoll, PennyStockLocks.com, PSNO.ORG, Penny Stock Newsletter, Damn Good Penny Picks, and Penny Picks reported recently on Bio-Matrix Scientific Group, Inc. (BMSN), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Bio-Matrix Scientific Group, Inc., by way of their wholly owned subsidiary, Regen BioPharma, Inc., is a biotechnology company based in La Mesa, California. They focus on identifying undervalued regenerative medicine patents in the stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/II clinical trials. Regen BioPharma's areas of interest include Diabetes, Chronic Obstructive Pulmonary Disease (COPD), Heart Related illness, as well as Circulatory issues.
Regen BioPharma is focusing on developing translational medicine platforms for the rapid commercialization of stem cell therapies and to advancing intellectual property (IP) licensed from entities, institutions, and universities that show promise towards fulfilling the purpose of increased quality of life. Regen BioPharma has assessed more than 20,000 stem cell related issued patents, narrowed down to 2,000 patents with commercial applicability. They have further identified 30 patents available for licensing. Their business model is to take multiple stem cell therapeutics to and through the human "safety and signal of efficacy" stage (Phase I/II clinical trials), followed by exit.

In September, Bio-Matrix Scientific Group announced that their subsidiary Regen BioPharma signed an agreement with Dr. Wei-Ping Min covering experiments requested by the Food and Drug Administration (FDA) in support of clearance for the Company's IND #15376 for use of HemaXellerate I in the treatment of drug refractory aplastic anemia.

Regen BioPharma filed an Investigational New Drug (IND) application for HemaXellerate I in February 2013 seeking permission from the FDA to initiate a ten patient clinical trial. Regen BioPharma has been in discussions with Dr. Wei-Ping Min, who also sits on the Company's scientific advisory board concerning responding to the FDA comments. On September 24, 2013, Dr. Min signed a services agreement for conducting the animal studies requested by the FDA.

Yesterday, Bio-Matrix Scientific Group announced that the Company’s Board of Directors authorized a distribution on a pro rata basis as a dividend in kind of 20,000,000 of the common shares of Regen BioPharma to holders of record of the outstanding common shares of Bio-Matrix Scientific Group as of the record date, and holders of record of the shares of any outstanding series of the preferred shares of Bio-Matrix Scientific Group as of the record date.

Bio-Matrix Scientific Group, Inc. (BMSN), closed Thursday's trading session at $0.0026, up 18.18%, on 144,279,182 volume with 307 trades. The average volume for the last 60 days is 27,880,486 and the stock's 52-week low/high is $0.0002/$0.0165.

OncoSec Medical, Inc. (ONCS)

PennyStocks24, Stock Analyzer, and Greenbackers reported earlier on OncoSec Medical, Inc. (ONCS), and we report on the Company today, here at the QualityStocks Daily Newsletter.

OncoSec Medical, Inc. is a biopharmaceutical company with headquarters in San Diego, California. The Company is developing their advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors. Their corporate mission is to pioneer and refine new electroporation technologies that endeavor to benefit patients and improve the quality of life for those whose skin cancers cannot be treated effectively with conventional treatment approaches.  

OncoSec's clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers. The Company’s ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution for less invasive and less expensive therapies that can reduce detrimental effects resulting from currently available cancer treatments. These currently available treatments include surgery, systemic chemotherapy, or immunotherapy and other treatment alternatives.

The basis of OncoSec’s core technology is upon their proprietary use of an electroporation platform to enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these targeted anti-cancer agents has demonstrated selective destruction of cancerous cells. This is while potentially sparing healthy normal tissues during early and late stage clinical trials.

This week, OncoSec Medical announced positive preliminary animal data demonstrating the benefits of combining the Company’s ImmunoPulse with anti-CTLA4 and anti-PD1 antibodies. Dr. Richard Heller, professor at Old Dominion University, summarized the initial results of this study at the Cancer Vaccines and Gene Therapy Meeting in Philadelphia, Pennsylvania. The study took place using a single tumor model; 40 mice (eight treatment groups) were treated with either ImmunoPulse alone, or in combination with anti-CTLA4, anti-PD1 or both at varying concentrations.

Results indicate that all treatment groups showed 100 percent regression of treated lesions in all mice, and that no mice died as a result of toxicity from treatment. The results from this initial study demonstrate that ImmunoPulse in combination with anti-CTLA4 or anti-PD1 is safe, effective, and does not have any contraindicated outcomes. Based on these positive results, OncoSec Medical’s intention is to continue testing combination approaches in more aggressive melanoma models that will support further evaluation of this approach in humans.

OncoSec Medical, Inc. (ONCS), closed Thursday's trading session at $0.257, down 0.39%, on 1,620,048 volume with 200 trades. The average volume for the last 60 days is 2,152,254 and the stock's 52-week low/high is $0.182/$0.485.

BlueFire Renewables, Inc. (BFRE)

SmallCapVoice, OTC Picks, M2 Communications, and FeedBlitz reported previously on BlueFire Renewables, Inc. (BFRE), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Headquartered in Irvine, California, BlueFire Renewables, Inc.'s main business includes development activities culminating in the design, construction, ownership and long-term operation of cellulosic ethanol production biorefineries utilizing the licensed Arkenol Technology in North America. Their secondary business is providing support and operational services to Arkenol Technology based biorefineries worldwide. BlueFire Renewables’ shares trade on the OTC Bulletin Board.

The Company is focusing on opportunities for converting cellulose fractions of municipal solid waste and other opportunistic feedstock into ethanol fuels. BlueFire Renewables formed to employ a patented Concentrated Acid Hydrolysis Technology Process for the conversion of cellulosic (Green Waste) waste materials to ethanol, and other viable alternatives to petroleum-derived fuels. Their technology has demonstrated production of ethanol and other petroleum displacing fuels from urban trash (post-sorted MSW), rice and wheat straws, wood waste and other agricultural residues. BlueFire is the exclusive North America licensee of the Arkenol Technology.

BlueFire Renewables’ plans include a biorefinery proposed for development and construction in conjunction with the DOE, previously located in Southern California, and now located in Fulton, Mississippi. This biorefinery will process woody biomass, mill residue, and other cellulosic waste (the Fulton Project). Moreover, the Company is evaluating other opportunities in North America.

Last week, BlueFire Renewables announced that the Company integrated a synergistic wood pellet production plant to their facility in Fulton, Mississippi. The reconfigured design will be a 9 million gallon per year ethanol plant integrated with a 400,000 ton per year wood pellet plant. The pellets will sell under long term contracts into the European mandated renewable energy market.

The Company previously announced the start of construction; they have completed the preliminary site work for the ethanol facility. The engineering and other development activities required are already underway to add to the pellet plant. The Company announced that synergistic partners will be announced upon the signing of the definitive agreements.

BlueFire Renewables, Inc. (BFRE), closed Thursday's trading session at $0.011, down 4.35%, on 350,000 volume with 6 trades. The average volume for the last 60 days is 292,477 and the stock's 52-week low/high is $0.008/$0.18.

Firemans Contractors, Inc. (FRCN)

Real Pennies reported earlier on Firemans Contractors, Inc. (FRCN), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Firemans Contractors, Inc. is a full service contractor headquartered in Fort Worth, Texas. The Company provides professional services for commercial and government clients. Their services include Road Improvements, Pavement Maintenance, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, and ADA Compliance. Firemans Contractors’ focus is on developing Business to Business (B2B) Franchise Opportunities throughout the U.S. The Company’s dedication is to providing superior service in parking lot maintenance and construction services.

Founded by a Fireman, Firemans Contractors supports firefighters for safer communities by giving a portion of the Company's profits to local Firefighter Associations. The Company is a member of the Franchise Association (IFA) and The Veteran Transition Franchise Initiative (VetFran). As a member, Firemans Contractors is expanding by way of franchise development, aimed to help the Company in expanding their market share.

As a franchisor, Firemans Contractors will provide franchisees with training and support. This includes the proprietary Firebase™ software platform, included along with other business tools and training for new franchisees of Firemans Contractors.

Q3 2013 highlights for the Company included and increase in revenues to $862,394, up 220 percent versus Q3 2012. They had a reduction in operational loss to $34,604 from $204,428, in comparison to Q3 2012. They also had an increase of Corporate Assets from $58,964, to $209,236 as of Q3 2013. In addition, Franchise Fees & Royalty Revenue increased to $84,234 through Q3 2013.

Today, Firemans Contractors provided a shareholder update and announced that the Company received clearance from the DTC (Depository Trust Company) as their "Plan for Growth" through franchising strategy sees, as the Company indicates, a positive future ahead. The DTC provided clearance on Firemans Contractors after a review and will continue accepting deposits of the Issue for depository and book-entry transfer services.

Renee Gilmore, Chief Executive Officer of Firemans Contractors, stated, "We're proud to announce this critical step in receiving DTC clearance. Our future is bright as The Plan for Growth through franchising reflects strong results from its current franchisees that are experiencing a 25 percent net profit in their first year of business."

Firemans Contractors, Inc. (FRCN), closed Thursday's trading session at $0.0042, down 16.00%, on 2,444,089 volume with 27 trades. The average volume for the last 60 days is 153,143 and the stock's 52-week low/high is $0.0016/$0.14.


The QualityStocks
Company Corner


Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0046, up 20.05%, on 245,217 volume with 3 trades. The stock’s average daily volume over the past 60 days is 2,247,229, and its 52-week low/high is $0.0025/$0.03.

Singlepoint, Inc. (SING) is a state-of-the-art mobile technology company and full-service mobile marketing agency. The company’s mobile commerce and communication platform allows clients to conduct business transactions, accept donations, and engage in targeted communication campaigns with their customers/donors through mobile devices.

The company is known for making any campaign instantly interactive via the mobile phone, enabling non-profit and for-profit organizations send more messages, create more awareness, and raise revenues and donations. The SinglePoint brand has been associated with media messaging campaigns for NBC, MTV, CBS, Univision and other top corporate entities.

Today, approximately 150 million web-enabled mobile phones exist in our nation alone. Javelin Strategy and Research predicts the highest growth for any payment type from now until 2018 will be in mobile payments. Rapid mobile adoption and the industry-wide push for mobile payments are anticipated to increase the total amount of mobile payments at point of sale to $5.4 billion in 2018.

SinglePoint is well positioned to capitalize on the growing mobile technology space. Key partnerships with companies such as Text2Bid, a leader in mobile auction technology, solidify the company’s foothold in the industry and provide multiple avenues for ongoing expansion. Moving forward with a solid business plan and carefully assembled management team, SinglePoint is poised for rapid growth. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

Singlepoint, Inc. Announces Engagement of QualityStocks Investor Relations Services

Singlepoint, Inc. Secures Partnership, Sales Rights with Mobile Auction Expert, Text2Bid™

SinglePoint, Inc. Partners with iATS Payments

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.209, up 16.11%, on 2,723,902 volume with 527 trades. The stock’s average daily volume over the past 60 days is 675,954, and its 52-week low/high is $0.13/$0.41.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.

A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.

In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation to Present at 12th Annual BIO Investor Forum October 8-9th, 2013

International Stem Cell Corporation to Present New Data From Parkinson's Disease Program at the American Neurological Association 2013 Annual Meeting

International Stem Cell Corporation Advances Parkinson's Disease Program Towards IND Stage

Calpian, Inc. (CLPI)

The QualityStocks Daily Newsletter would like to spotlight Calpian, Inc. (CLPI). Today, Calpian, Inc. closed trading at $1.75, up 16.67%, on 8,352 volume with 10 trades. The stock’s average daily volume over the past 60 days is 5,147, and its 52-week low/high is $0.88/$2.65.

Calpian, Inc. (CLPI) has forged a powerful combination of steady cash flow here in the U.S. on the one hand, and explosive growth potential abroad in India on the other. Both business units are growing fast and creating huge value that has so far gone largely overlooked due to the company’s rapid rise.

Calpian is a leader in the U.S. business for providing access to credit and debit card payment processors for merchants and also for making investments in the resulting cash flow streams. Calpian's management team, with over 60 years of combined experience in payments, has also tapped into a super-hot growth opportunity in India where it is the leader in consumer payments using the cell phone - the most powerful financial trend in the developing world today. The company's revenues in India grew 300% year to year and are headed for triple digit growth again in 2013. Examples of this service in other countries like Kenya show that consumers need this simple payment tool and adopt it quickly. In Kenya, over 90% of the adult population has adopted a mobile phone money transfer system known as M-PESA, which produces over $100 million pretax profit after only 7 years in business. Calpian is providing this same service in India via Money on Mobile (MoM). India is a market at least 30 times larger than Kenya with vast potential. Calpian is the undisputed market leader in the space and looks poised to dominate the largest market for this service in the world with almost 1 billion cell phones.

In the U.S., the company has carved out a solid niche in the growing $1B plus annual residuals space for credit card usage by providing a silver bullet solution including their own gateway that merchants use to connect with large payment processors. Calpian is providing its merchant services through its wholly owned subsidiary, Calpian Commerce continues to sign merchants to card processing contracts, while Calpian itself continues acquiring additional recurring monthly cash flows from the over 10,000 smaller Independent Sales Organizations (dealers) throughout the U.S. The management team has been together for decades refining this business model through over 200 acquisitions in their careers before making it public in 2010. The team is experienced and well known throughout the industry as the go-to guys for making a deal.

In India, with Calpian acquiring an interest in March 2012 in Digital Payments Processing Limited (DPPL), which delivers the payment processing service for the Money on Mobile solution, it has taken off with incredible force, signing an incredible 53 million consumers though its vast network of 143,000 retailers (and growing at least 3,000 per month) so far. This astonishing growth is thanks in large part to how elegantly the company's mobile payment application, which is already seen as the “PayPal” of India, satisfies all the needs of the average Indian consumer, distributor, and retailer alike. The vast swathes of under-banked and unbanked consumers in India represent the tip of a much larger global iceberg for this solution as well, a solution whose backbone is simple SMS text protocol, and which bundles all the right incentives together for emerging markets. MoM is the runaway leader at this time in India pacing at 20 times larger than its nearest competitor. Disclaimer

Calpian, Inc. Company Blog

Calpian, Inc. News:

Calpian Inc. Indian Subsidiary Money on Mobile Announces Direct Bill Payment Integration with Indian Utilities Covering Over 25 Million Consumers

Calpian Inc. CEO Harold Montgomery Discusses the Company’s Indian Subsidiary, Money-on-Mobile, to Viewers of CorporateProfile.com

Calpian to Present at the 15th Annual Rodman and Renshaw Conference

Epazz Inc. (EPAZ)

The QualityStocks Daily Newsletter would like to spotlight Epazz Inc. (EPAZ). Today, Epazz Inc. closed trading at $0.0008, up 14.29%, on 1,463,037 volume with 10 trades. The stock’s average daily volume over the past 60 days is 13,557,150 and its 52-week low/high is $0.0006/$0.0099.

Epazz Inc. (EPAZ) is a leading cloud-based software company focused on providing customized cloud applications to Fortune 500 enterprises, government agencies, and higher education institutions. Targeting a strong growth industry, the company is rapidly expanding via strategic acquisitions, a full suite of in-house products and services, and diversified streams of income.

The fully reporting company is demonstrating substantial performance in a competitive industry, completing six acquisitions while maintaining organic subsidiary growth. In the last three years, Epazz revenues have increased by more than 300%. The company will produce its first spinoff with “Project Flex” and issue a stock dividend to shareholders of record on the record date.

As an enterprise-wide software company, Epazz is adeptly serving the increasing information technology demand of the 21st century. According to IDC, the premiere global market intelligence firm, the IT cloud services industry is expected to grow from $40 billion to $100 billion in just four years. Management anticipates the company’s growth to accelerate as the market for its technology solutions continues to expand.

Epazz BoxesOS™ v3.0 is the complete business web-based software package for small to mid-size businesses, Fortune 500 enterprises, government agencies, and higher education institutions. The turnkey enterprise system, which includes content, integration, customization, and marketing services, provides many of the web-based applications organizations would have to otherwise buy separately. Disclaimer

Epazz Inc. Blog

Epazz Inc. News:

Epazz Revenues Increase Over 1,000 Percent Since Going Public

Epazz's Short Interest in Market Climbs; Short Interest in Excess of 47 Percent of Total Volume for Sep 2013

Epazz Transitioning Into a Holding Company via Acquisitions & Spin-offs Business Model Update

GNCC Capital, Inc. (GNCP)

The QualityStocks Daily Newsletter would like to spotlight GNCC Capital, Inc. (GNCP). Today, GNCC Capital, Inc. closed trading at $0.0009, up 12.50%, on 76,139,672 volume with 140 trades. The stock’s average daily volume over the past 60 days is 6,105,253, and its 52-week low/high is $0.0006/$0.09.

GNCC Capital, Inc. (GNCP) is a gold and silver exploration company with six different projects, all of which were carefully selected due to their outstanding characteristics. The company’s geologists will supervise an extensive exploration program for these projects to prove up reserves through geological surveys and a substantial number of carefully planned drilling programs.

The company’s initial exploration properties, located in Arizona, consist of Esther Basin, Burnt Well, Clara Gold, Kit Carson, Silverfields, and Potts Mountain. GNCC Capital plans to create significant value for its initial properties portfolio through continued exploration and joint ventures, as well as through acquiring additional gold and silver exploration assets.

GNCC Capital currently holds circa 80% of its assets in gold exploration properties. The strong rise in gold prices over recent years make this company attractive to investors seeking to benefit from the increasing value of precious metals. Backed by a world-class management team with decades of experience in the financial and mining sectors, GNCC Capital is well positioned to capitalize on the upward trend.

The company’s focus is creating value for its shareholders, employees, and business and social partners through responsible and safe exploration, mining, and marketing. While gold exploration is the company’s main focus, GNCC Capital will take advantage of value-creating opportunities in other minerals where it can leverage existing assets, skills, and experience. Disclaimer

GNCC Capital, Inc. Company Blog

GNCC Capital, Inc. News:

GNCC Capital, Inc. -- Potential Low Cost Mining at Gold Hills Property

GNCC Capital, Inc. Completes the Acquisition of the White Hills Gold Properties

GNCC Capital, Inc. Nears Completion of the Acquisition of the White Hills Gold Properties

Advaxis, Inc. (ADXS)

The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $5.60, up 6.87%, on 43,481 volume with 147 trades. The stock’s average daily volume over the past 60 days is 33,994, and its 52-week low/high is $2.60/$19.375.

Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.

The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.

Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.

The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer

Advaxis, Inc. Company Blog

Advaxis, Inc. News:

Advaxis Lead Product Candidate ADXS-HPV in Combination with PD-1 Antibody Significantly Improves Immune and Therapeutic Efficacy in Preclinical Study

Advaxis Announces Three Abstracts Accepted for Presentation at Society for Immunotherapy of Cancer Annual Meeting

Advaxis Appoints Daniel J. O'Connor President and CEO and Elects Dr. James Patton Non-Executive Chairman of the Board

OxySure Systems, Inc. (OXYS)

The QualityStocks Daily Newsletter would like to spotlight OxySure Systems, Inc. (OXYS). Today, OxySure Systems, Inc. closed trading at $0.73, up 1.39%, on 1,910 volume with 5 trades. The stock’s average daily volume over the past 60 days is 8,125, and its 52-week low/high is $0.35/$2.75.

OxySure Systems, Inc. (OXYS) is a medical technology company focused on developing, manufacturing, and distributing specialty respiratory and medical solutions. The company has developed a unique platform technology that instantly creates medically pure oxygen from two dry, inert powders, allowing oxygen to be delivered on demand. This cutting-edge technology has already been granted FDA-approved for commercial sale.

The company is targeting multiple enormous end markets with no direct competition. OxySure initially plans to focus on the 102,265 educational campuses, 350,735 manufacturing facilities, 350,000 churches, 12 million recreational vehicles (RVs), 8 million boats and yachts, 950,000 restaurants, and hundreds of thousands of other commercial and municipality facilities in the U.S. Outside the US, OxySure has also already signed significant distribution agreements, including Australia, New Zeeland, the United Kingdom, the Netherlands, Luxembourg, Belgium, Brazil, and South Africa. OxySure’s potential market is at least as large as AEDs and potentially as large as fire extinguishers, which together total at least 500+ million units worldwide.

OxySure’s flagship product, OxySure Model 615, introduces the first new oxygen technology in 50 years. There are no compressed tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, and no required training, and the technology is both safe and easy-to-use for the layperson. It can be placed virtually anywhere to help save lives by bridging the gap between a medical emergency and the arrival of first responders on the scene.

The company aims to capitalize on market opportunities primarily through partnerships with distributors and OEM customers. Protected by numerous issued patents and patents pending, the company’s products are available over-the-counter without the need for a prescription and has already saved thousands of lives around the globe during various types of medical emergencies. Disclaimer

OxySure Systems, Inc. Company Blog

OxySure Systems, Inc. News:

OxySure Systems, Inc. to Exhibit at the National Safety Council's (NSC) 2013 Congress & Expo

OxySure Systems, Inc. Announces Progress on CE Marking

The Stock Radio Interviews OxySure Systems’ CEO, Highlighting Life Saving “Oxygen from Powder” Technology

Mabwe Minerals Inc. (MBMI)

The QualityStocks Daily Newsletter would like to spotlight Mabwe Minerals Inc. (MBMI). Today, Mabwe Minerals Inc. closed trading at $0.28, up 0.07%, on 6,200 volume with 5 trades. The stock’s average daily volume over the past 60 days is 22,281, and its 52-week low/high is $0.06/$0.70.

Mabwe Minerals Inc. (MBMI) is a U.S. based natural resources and hard asset company focused on the mining, logistics, and commercial sales of industrial minerals and metals, with a particular emphasis on barite. The company's operations are conducted through its Zimbabwe affiliate, Mabwe Mineral Zimbabwe (Private) Ltd. Transitioning into commercial production, MBMI's company fundamentals are well positioned with virtually no debt and key strategic partnerships in place.

Along with its affiliate, Mabwe Minerals Zimbabwe (Private) Ltd., an indigenous Zimbabwe company, the company owns 100% of the mineral & metal rights to Dodge Mine. The mine will be managed by the company's minority owned partner, WGB Kinsey & Company, Zimbabwe's most experienced mining & construction company representing four generations of Kinsey leadership. Management believes WGB Kinsey & Company has all the necessary equipment and management experience to efficiently perform all the mining operations at Dodge Mine.

The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc. Hydrothermal barite deposits throughout Dodge Mine represent the highest grade of new barite sources to be brought into commercial production in years. A third party oil & gas drilling sector geologist recently confirmed that the multiple barite deposits are considered "World Class" in quality and highly efficient to mine via open pit extraction following the barite veins and salvaging large percentages of barite within the halo zones via jigging systems.

With a continuing worldwide shortage of high-grade barite, Mabwe Minerals is in the right place at the right time. The company's current customer uses barite as a weighting agent in oil & gas drilling applications in the Gulf of Mexico, home to the largest concentration of active rigs in the world. Coupled with the recent massive discovery of oil & gas off the coast of neighboring Mozambique along with new drilling contracts expected in the region, MBMI is in an attractive geographical location to capture the expected demands of this emerging market. Moving from an exploration stage company into commercial barite production, Mabwe Minerals is well positioned to generate significant shareholder returns. Disclaimer

Mabwe Minerals Inc. Company Blog

Mabwe Minerals Inc. News:

Mabwe Minerals Launches New Web Site as Affiliate Finalizes Barite Specification Sheets to Commence Barite Qualification

Mabwe Minerals Completes Strategic Alliances With Steinbock Minerals Ltd. and Yasheya Ltd.

Mabwe Minerals Commences Mining Operations at Dodge Mine


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Information Solutions Group


Alternative Energy


National Inflation Association

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251